HLA class I antigen down-regulation in human cancers: T cell immunotherapy revives an old story
2. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen down-regulation in human cancers: T cell immunotherapy revives an old story. Mol Med Today 1999: 5: 178-86.
Implications for immunosurveillance of altered HLA class I phenotypes in human tumors
3. Garrido F, Ruiz-Cabello F, Cabrera T et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today 1997: 18: 89-95.
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line
4. Torres MJ, Ruiz-Cabello F, Skoudy A et al. Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens 1996: 47: 372-81.
Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region
5. Tamiya G, Ota M, Katsuyama Y et al. Twenty-six new polymorphic microsatellite markers around the HLA-B, -C and -E loci in the human MHC class I region. Tissue Antigens 1998: 51: 337-46.
HLA class I phenotype and genotype alterations in cervical carcinomas and derivate cell lines
6. Koopman LA, Mulder A, Corver WE et al. HLA class I phenotype and genotype alterations in cervical carcinomas and derivate cell lines. Tissue Antigens 1998: 51: 623-36.
HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas
7. Feenstra M, Veltkamp M, van Kuik J et al. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 1999: 54: 235-45.
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors
8. Jiménez P, Cantón J, Collado A et al. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer 1999: 83: 91-7.
Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides
9. Benítez R, Godelaine D, López Nevot MA et al. Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens 1998: 52: 520-9.
In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumor cell variants expressing a single HLA class I allele
10. Real LM, Jiménez P, Canton J et al. In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumor cell variants expressing a single HLA class I allele. Int J Cancer 1998: 75: 317-23.
